Another interesting idea is the development of TXNIP inhibitors, which represents a promising therapeutic strategy for enhancing immunity against pathogenic bacterial infections, increasing the antioxidant activity of Trx, and reducing apoptosis. Here, TXN is linked to bacterial infectious disease.